Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease

Fig. 3

Liver transcriptome profile. (A) Heatmap of the DEGs expression between MASH group and non-MASH group. (B) Volcano plot of differential expression. (C) Bar chart of GO enrichment analysis. (D) Bubble chart of KEGG pathway enrichment analysis. RNA sequencing was randomly selected for 9 samples in the non-MASH group and 32 samples in the MASH group. DEGs, differentially expressed genes; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; MASH, metabolic dysfunction-associated steatohepatitis

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X